Symbol="HRMY"
AssetType="Common Stock"
Name="Harmony Biosciences Holdings"
Description="Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and markets therapies for patients with rare neurological disorders. The company is headquartered in Plymouth Meeting, Pennsylvania."
CIK="1802665"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="630 W GERMANTOWN PIKE, SUITE 215, PLYMOUTH MEETING, PA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="1951203000"
EBITDA="171098000"
PERatio="9.71"
PEGRatio="None"
BookValue="8.09"
DividendPerShare="0"
DividendYield="0"
EPS="3.35"
RevenuePerShareTTM="8.37"
ProfitMargin="0.401"
OperatingMarginTTM="0.294"
ReturnOnAssetsTTM="0.145"
ReturnOnEquityTTM="0.547"
RevenueTTM="498856000"
GrossProfitTTM="354374000"
DilutedEPSTTM="3.35"
QuarterlyEarningsGrowthYOY="0.436"
QuarterlyRevenueGrowthYOY="0.254"
AnalystTargetPrice="58.5"
TrailingPE="9.71"
ForwardPE="25.64"
PriceToSalesRatioTTM="8.31"
PriceToBookRatio="10.12"
EVToRevenue="8.39"
EVToEBITDA="27.25"
Beta="0.433"
num_52WeekHigh="62.09"
num_52WeekLow="29.81"
num_50DayMovingAverage="34.33"
num_200DayMovingAverage="42.09"
SharesOutstanding="59940000"
DividendDate="None"
ExDividendDate="None"
symbol="HRMY"
open="32.04"
high="32.82"
low="31.70"
price="32.52"
volume="306380.00"
latest_trading_day="2023-08-25"
previous_close="31.89"
change="0.63"
change_percent="1.9755%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="73"
trend_strength="Absent or Weak Trend"
buying_signal="High Volatility / Hold Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="27"
Volume_recent_avg="520018"
Change_recent_avg="-0.11"
Delta_recent_avg="1.16"
Variance_recent_avg="0.58"
Change_ratio_recent_avg="-0.33"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="27"
Aroon_momentum_negative="73"
image_negative_thumbnail_id_1="508"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0097.jpeg"
image_negative_thumbnail_id_2="115"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0061.jpeg"
image_neutral_thumbnail_id_1="533"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0066.jpeg"
image_neutral_thumbnail_id_2="534"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0065.jpeg"
image_positive_thumbnail_id_1="951"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0113.jpeg"
image_positive_thumbnail_id_2="700"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0008.jpeg"
image_professor_thumbnail_id_1="1183"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0017.jpeg"
image_professor_thumbnail_id_2="1173"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0007.jpeg"
